Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Non-Current Deferred Tax Liability (2016 - 2017)

Lisata Therapeutics' Non-Current Deferred Tax Liability history spans 8 years, with the latest figure at $1.1 million for Q1 2017.

  • For Q1 2017, Non-Current Deferred Tax Liability rose 13.61% year-over-year to $1.1 million; the TTM value through Mar 2017 reached $1.1 million, up 13.61%, while the annual FY2016 figure was $1.1 million, 14.8% up from the prior year.
  • Non-Current Deferred Tax Liability reached $1.1 million in Q1 2017 per LSTA's latest filing, up from $1.1 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $35.5 million in Q4 2013 to a low of $932662.0 in Q4 2015.
  • Average Non-Current Deferred Tax Liability over 5 years is $9.5 million, with a median of $4.1 million recorded in 2013.
  • Peak YoY movement for Non-Current Deferred Tax Liability: soared 369.11% in 2014, then crashed 94.87% in 2015.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $35.5 million in 2013, then tumbled by 48.87% to $18.2 million in 2014, then plummeted by 94.87% to $932662.0 in 2015, then rose by 14.8% to $1.1 million in 2016, then rose by 4.63% to $1.1 million in 2017.
  • Per Business Quant, the three most recent readings for LSTA's Non-Current Deferred Tax Liability are $1.1 million (Q1 2017), $1.1 million (Q4 2016), and $1.1 million (Q3 2016).